ClinicalTrials.govpublic full text
A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation
conduct disorder, disruptive behavior disorder, oppositional defiant disorder, disruptive behavior disorder not otherwise specified, adhd, risperidone, antipsychotropic agents, children, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980525
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.